GlassScriptPhysician profile
Winston Timothy Capel
NPI 1326012436
$9,025.94
in general payments reported to CMS, 2019-2025
33 companies · $852 in 2025
The $852 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $537 · 2020: $2,121 · 2021: $625 · 2022: $2,540 · 2023: $1,184 · 2024: $1,167 · 2025: $852.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,951 · Travel and Lodging: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,950.95 |
| Travel and Lodging | $252.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,813.50 | 2021-2024 | Synchromedii, Mazor X System, Rialto Si Fusion System |
| Aesculap Implant Systems, LLC | $1,710.69 | 2019-2021 | |
| Si-Bone, INC. | $941.97 | 2019-2023 | |
| Providence Medical Technology, INC. | $762.48 | 2020-2025 | |
| Carlsmed, INC. | $331.82 | 2024-2025 | Aprevo |
| Globus Medical, INC. | $321.73 | 2024-2025 | Modulus, Sable, Modulus |
| Boston Scientific Corporation | $285.14 | 2023-2025 | Wavewriter Alpha Prime 16 |
| Orthofix Medical, INC. | $241.86 | 2019-2025 | Cervical-Stim, Spinal-Stim, Spinal-Stim |
| Medtronic USA, INC. | $221.94 | 2019-2020 | |
| 7d Surgical INC. | $209.30 | 2019 | |
| Ossdsign USA Incorporated | $147.85 | 2025 | Ossdsign Catalyst |
| Nuvasive, INC. | $118.14 | 2022-2023 | Simplify Cervical Artificial Disc |
| Elutia, INC. | $115.38 | 2020 | |
| Baxter Healthcare | $105.81 | 2022 | |
| 4web, INC. | $90.00 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $70.41 | 2022-2023 | Magellan |
| Organogenesis INC. | $62.99 | 2023 | Puraply |
| Amgen INC. | $53.60 | 2023-2025 | Evenity, Prolia |
| Spineology INC. | $42.78 | 2024-2025 | Optimesh Expandable Interbody Fusion System |
| Ethicon US, LLC | $41.33 | 2024 | Dermabond |
| Solventum Corporation | $41.14 | 2025 | V.A.C. Veraflo, V.A.C.Ulta, Prevena |
| Kerecis Limited | $39.08 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Sanara Medtech INC. | $37.56 | 2025 | Celleraterx |
| Prime Surgical, LLC | $32.73 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $31.25 | 2023 | Seglentis |
| Integra Lifesciences Corporation | $25.51 | 2024 | Instruments-Orthopedic, Integra Duo, Integra |
| Smith+Nephew, INC. | $23.31 | 2023 | Journey II |
| Avanos Medical | $20.82 | 2023 | Trivisc Sodium Hyaluronate |
| Spinal Simplicity, LLC | $18.76 | 2024 | Ha Minuteman G3-R |
| Bioventus LLC | $17.44 | 2022 | |
| Djo, LLC | $16.78 | 2024 | Cmf |
| Radius Health, INC. | $16.51 | 2024 | Tymlos |
| Ermi LLC | $16.33 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winston Capel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.